Overview
Dyskeratosis congenita (DKC) is an inherited disorder. Symptoms may include abnormal skin pigmentation, abnormal nail growth, and leukoplakia (white patches inside the mouth), but many patients can have DKC without any of these symptoms. Patients with DKC are predisposed to bone marrow failure, some cancers, and pulmonary problems. A registry was established in 1995 to study the clinical features of this disease.
Classical symptoms of rash, nail abnormalities, and leukoplakia typically begin to surface between the ages of five and ten years but these symptoms may be absent in many patients. DKC has been diagnosed at all ages from infancy until well into adulthood.
Outstanding Care Team
The medical team at Seattle Children's, a parent organization of Seattle Cancer Care Alliance, has a long history of successfully caring for children and teens who have DKC. These renowned specialists work together to improve your child's quality of life and conquer this disease.
Medical therapy for bone marrow failure diseases is provided at Seattle Children's. If your child's health-care team determines that the best course of action is a bone marrow transplant, your child will receive this treatment through Seattle Cancer Care Alliance, ranked first in outcomes in a four-year study by the National Marrow Donor Program (NMDP) that measured one-year survival rates of patients among 122 transplant centers in the United States.
Dyskeratosis Congenita (DKC) Facts
Learn about the risk factors and symptoms of Dyskeratosis Congenita (DKC), how it is diagnosed and how its stages are determined.Our Doctors
Our doctors are members of Fred Hutchinson Cancer Research Center and faculty from UW Medicine and Seattle Children's. They are the best of the best who work as a team to care for people with Dyskeratosis Congenita (DKC)Treatment Options
Regardless of the stage of your illness, the unsurpassed expertise of our physicians makes SCCA the ideal treatment center for Dyskeratosis Congenita (DKC).Participate in a Study
As a world-class treatment center, SCCA provides patients with the best and most current therapies available. Clinical studies bring promising new treatments to patients faster. And participating in a study gives patients at least the best, current treatment, as well as the satisfaction that they are helping others with Dyskeratosis Congenita (DKC).Patient Support
Because treatment for Dyskeratosis Congenita (DKC) isn't easy, special support for patients is essential. SCCA has several programs, classes, and services to assist patients and their families.
Children and Clinical Studies
Learn why half of all American children with cancer take part in a study.
Find a Doctor
Find a physician by name, diagnosis, or clinical specialty.
Find a physician by name, diagnosis, or clinical specialty.